Status:
RECRUITING
Sputum-guided Treatment With Comprehensive Care Management in COPD - A Randomized-controlled Trial
Lead Sponsor:
McMaster University
Collaborating Sponsors:
Hamilton Academic Health Sciences Organization
St. Joseph's Healthcare Hamilton
Conditions:
COPD
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a lung condition affecting 1 in 6 Canadians and does not have a cure. Flare-ups of COPD are the most common reason someone goes to hospital in Canada. T...
Detailed Description
STRIVE is a randomized-controlled trial comparing a two-pronged intervention, including sputum-biomarker-directed treatment of airway inflammation, and comprehensive care management, to usual care, fo...
Eligibility Criteria
Inclusion
- \>=2 exacerbations of COPD in the last 12-months, FEV1/FVC\<0.7 or radiologic emphysema, with a \>-10 pack-year smoking history
Exclusion
- severe mental illness not controlled by medication or life-expectancy less than 6-months
Key Trial Info
Start Date :
May 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT04890938
Start Date
May 27 2022
End Date
August 1 2025
Last Update
November 21 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamilton General Hospital
Hamilton, Ontario, Canada, L8L 2X2
2
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6